Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21 (APP21)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00583752
Recruitment Status : Active, not recruiting
First Posted : December 31, 2007
Last Update Posted : January 8, 2018
United States Department of Defense
Information provided by (Responsible Party):
David M Lubaroff, University of Iowa